Glycomine dedicates funds for CDG Research

Glycomine, raises $12M and a part o that budget will be dedicated to PMM2-CDG (CDG Type Ia) Studies. This company came to the 2nd World Conferene on CDG 2015, organized by The Portuguese Association for CDG (APCDG) and partners. Glycomine will also attent the 3rd World Conference on CDG 2017 in Leuven.

We request all patient groups and professionals to share this information and to save the date for the 3rd World Conference on CDG 2017. Glycomine's press release is HERE. Learn more about these Breaking News!